Adult Vaccines Market Report 2023 (Global Edition)

Global Adult Vaccines Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Adult Vaccines Industry growth. Adult Vaccines market has been segmented with the help of its Vaccine, Technology Vaccine Type, and others. Adult Vaccines market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Adult Vaccines industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

By Vaccines, the Influenza segment has the major revenue share of Adult VaccineMarket!

Based on Vaccines, the market is segmented into human papillomavirus, influenza, zoster, hepatitis, and others. The Influenza segment has the major revenue share during the forecast period. Increasing cases of asthma, pneumonia, acute respiratory infection, and other diseases caused by influenza are forecasted to dominate the target market.

• Hepatitis
• Human Papillomavirus
• Influenza
• Zoster
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Adult Vaccines Industry. Request a Free Sample PDF!

By Technology, the Recombinant segment is forecasted to dominate the Adult Vaccines Market!

By Technology, the market is segmented into inactivated viral/bacterial vaccines, live attenuated vaccines, toxoid vaccines, conjugate vaccines, and recombinant vaccines, The Recombinant segment is forecasted to dominate the global market, due to higher production, sales, and demand for recombinant.

• Live Attenuated Vaccines
• Inactivated Viral/Bacterial Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Conjugate Vaccines

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Adult Vaccines market report 2023 Edition by contacting our team.

Adult Vaccines Vaccine Type Segment Analysis

By Vaccine-type, the market is segmented into multivalent vaccines and monovalent vaccines. The Multivalent vaccines segment has the highest revenue share due to increasing incidences of bacterial and viral diseases boosting the demand for the target market.

• Monovalent
• Multivalent

Regional Analysis of the Adult Vaccine Market:

North America and Europe dominate the global adult vaccine market with the highest revenue share. This is attributed to the increasing research and development infrastructure in this region fuels the growth of the market. Furthermore, Asia Pacific is forecasted to dominate the global market in terms of growth rate. Various government associations have introduced various programs to promote awareness among people towards diseases such as DYP, measles, and many others in the region in the countries.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

Adult Vaccine Industry News:

GlaxoSmithKline plc announced US FDA approval of Priorix

June 2022, GlaxoSmithKline plc announced that they submitted a Biologics License Application (BLA) to the US FDA for its experimental vaccination PRIORIX. This vaccine is used for the prevention of mumps, rubella, and measles in individuals 12 months old and older over. Additionally, 100 nations have granted licenses for the vaccine, initially registered in Germany.

Source: https://www.gsk.com/en-gb/media/press-releases/gsk-announces-us-fda-approval-of-priorix-for-the-prevention-of-measles-mumps-and-rubella-in-individuals-12-months-of-age-and-older/

Top Companies Market Share in Adult Vaccines Industry: (In no particular order of Rank)

• GlaxoSmithKline
• Sanofi Pasteur
• Merck
• Novartis
• Pfizer
• BioCSL (Seqirus)
• Protein Sciences
• Confidential Data
• Access The Paid Version
• Data Hidden

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..